These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2893022)

  • 41. A multi-centre general practice trial of mazindol in the treatment of obesity.
    Maclay WP; Wallace MG
    Practitioner; 1977 Mar; 218(1305):431-4. PubMed ID: 322112
    [No Abstract]   [Full Text] [Related]  

  • 42. Height and clinical course of Duchenne muscular dystrophy.
    Coakley JH; Griffiths RD; Edwards RH
    Am J Med Genet; 1989 Apr; 32(4):552-4. PubMed ID: 2774003
    [No Abstract]   [Full Text] [Related]  

  • 43. [Value of mazindol in Gélineau's disease. Apropos of 10 cases].
    Vespignani H; Weber M; Atlas P; Barroche G
    Rev Electroencephalogr Neurophysiol Clin; 1986 Oct; 16(3):317-22. PubMed ID: 3809694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A double-blind trial of mazindol using a very low calorie formula diet.
    Baird IM; Howard AN
    Int J Obes; 1977; 1(3):271-8. PubMed ID: 363631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mazindol in the treatment of Parkinson's disease.
    Delwaide PJ; Martinelli P; Schoenen J
    Arch Neurol; 1983 Dec; 40(13):788-90. PubMed ID: 6357158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Results in the treatment of obesity by Mazindol (AN 448 Sandoz) in hospitalized subjects using the method of double-blind trial (author's transl)].
    Kreze A; Velemínsky J; Toman A
    Bratisl Lek Listy; 1976 May; 65(5):537-43. PubMed ID: 788862
    [No Abstract]   [Full Text] [Related]  

  • 47. Double-blind evaluation of the effects of mazindol on pain, depression, anxiety, appetite, and activity in terminal cancer patients.
    Bruera E; Carraro S; Roca E; Barugel M; Chacon R
    Cancer Treat Rep; 1986 Feb; 70(2):295-8. PubMed ID: 3512080
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Teronac in the treatment of obesity].
    Zahorska-Markiewicz B
    Pol Tyg Lek; 1976 Jun; 31(25):1085-7. PubMed ID: 781638
    [No Abstract]   [Full Text] [Related]  

  • 49. Amphetamine, mazindol, and fencamfamin in narcolepsy.
    Shindler J; Schachter M; Brincat S; Parkes JD
    Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1167-70. PubMed ID: 2859077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allopurinol ineffective in Duchenne muscular dystrophy.
    Bretag AH; Stern LM; Ballard FJ; Tomas FM; Cooper DM; Fewings JD; Goldblatt E
    Lancet; 1981 Jan; 1(8214):276. PubMed ID: 6109925
    [No Abstract]   [Full Text] [Related]  

  • 51. Verapamil in Duchenne muscular dystrophy.
    Emery AE; Skinner R; Howden LC; Matthews MB
    Lancet; 1982 Mar; 1(8271):559. PubMed ID: 6120408
    [No Abstract]   [Full Text] [Related]  

  • 52. Letter: Prednisone in Duchenne muscular dystrophy.
    Munsat TL; Walton JN
    Lancet; 1975 Feb; 1(7901):276-7. PubMed ID: 46418
    [No Abstract]   [Full Text] [Related]  

  • 53. Ineffectiveness of allopurinol in Duchenne muscular dystrophy.
    Doriguzzi C; Bertolotto A; Ganzit GP; Mongini T; Palmucci L
    Muscle Nerve; 1981; 4(2):176-8. PubMed ID: 7010155
    [No Abstract]   [Full Text] [Related]  

  • 54. Letter: Prednisone in Duchenne muscular dystrophy.
    Lancet; 1975 Feb; 1(7903):397-8. PubMed ID: 46545
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of mazindol (teronac) on various hormonal indicators in children with simple obesity].
    Komorowski JM; Zwaigzne-Raczyńska J; Owczarczyk I; Gołebiowska M; Zarzycki J
    Pediatr Pol; 1982 Apr; 57(4):241-6. PubMed ID: 6755371
    [No Abstract]   [Full Text] [Related]  

  • 56. Slowed gastric evacuation accounts for the reduction of food intake by anorectic drugs.
    Jonderko K; Kucio C; Skrzypek D
    Eur J Clin Nutr; 1988 Jul; 42(7):627-31. PubMed ID: 3066620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Importance of mazindol in the treatment of narcolepsy.
    Vespignani H; Barroche G; Escaillas JP; Weber M
    Sleep; 1984; 7(3):274-5. PubMed ID: 6484432
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of mazindol on dystrophic mice and on growth in young rats.
    Coakley JH; Jackson MJ; Wagenmakers AJ; Ensor D; Edwards RH
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 92(2):385-9. PubMed ID: 2565192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mazindol.
    Med Lett Drugs Ther; 1982 Oct; 24(621):98. PubMed ID: 7144688
    [No Abstract]   [Full Text] [Related]  

  • 60. [Comparative trial on the effects of diet, mazindol, and placebo in the treatment of exogenous obesity (author's transl)].
    Mies R
    Med Klin; 1976 Nov; 71(46):2013-6. PubMed ID: 995040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.